(PharmaNewsWire.Com, September 21, 2017 ) The Latin America Platelet Aggregation Devices Market was worth USD 19.2 million in 2016 and is estimated to be growing at a CAGR of 18.7%, to reach USD 45.2 million by 2021. The process in which blood platelets, a type of blood cells assemble together to form blood clot at the site of injury is called platelet aggregation. This process is critical to achieve homeostasis. Platelets are also involved in inflammation and other pathological situations.
Platelet disorders occur in some people either due to genetic reasons or due to some other disease. This causes abnormalities in the formation of clots and result in heavy bleeding in case of injuries. Platelet aggregation tests are performed to assess the extent of aggregation and with the use of platelet aggregation devices clot formation cam be assisted in case of abnormalities.
With increase in number of surgical procedures, increasing popularity for antiplatelet therapy, growing aging population and increasing awareness in healthcare professionals regarding the benefits of platelet aggregation tests are the major factors driving the market growth. However, high purchase cost of devices and lack of skilled personnel are restraining the market growth.
The Latin America market for platelet aggregation devices is segmented by product, applications, end user and by region. Based on product, the market is segmented into systems, reagents and consumables and accessories. Platelet aggregation systems hold the largest market share due to the increasing automation of aggregation testing procedures. Based on application, the market is segmented into clinical applications and research applications. Clinical applications are again segmented into cardiovascular applications, orthopedic applications and other clinical applications. Clinical applications segment holds the largest market share due to the increased adoption of aggregator devices by healthcare professionals. Based on end user, the market is segmented into standalone hospitals, diagnostic laboratories, research and academic institutes and other end users. Standalone hospitals are expected to hold the largest market share in end users segment due to the increase in platelet disorders and increasing use of platelet therapy for cancer patients.
Based on region, Latin America market is divided into Brazil, Argentina, Mexico and rest of South America. The platelet aggregation market is expected to grow significantly in this region due to the increase in government initiatives to develop healthcare sector in developing countries like Brazil and Mexico.
Some of the major companies in the platelet aggregation devices market are Helena Laboratories Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Accriva Diagnostics, Sentinel CH. S.p.A., Bio/Data Corporation, Tem Group and Aggredyne, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
